North America Cell Culture Market

The North America cell culture market is anticipated to reach USD 20.38 billion by 2030 from USD 11.86 billion in 2025, at a CAGR of 11.4% during the forecast period. Major factors supporting growth in the North America cell culture market include strong public research funding and steady private investment in life sciences.

To know about the assumptions considered for the study download the pdf brochure

The North America cell culture market is consolidated. Prominent players in the North America cell culture market are Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Corning Incorporated (US), Agilent Technologies, Inc. (US), and Becton, Dickinson and Company (BD) (US), among others.

• In April 2025, Thermo Fisher Scientific launched 5L DynaDrive Single-use bioreactor to simplify and accelerate process development.
• In December 2023, Danaher acquired Abcam Limited, a provider of validated antibodies, reagents, biomarkers, and assays crucial for drug discovery, life sciences research, and diagnostics. Within Danaher's Life Sciences segment, Abcam will continue to operate independently, aligning with Danaher's mission to advance disease understanding and expedite drug discovery.

Thermo Fisher Scientific Inc. is a leaders in the North America cell culture market. The growth of this company is supported by a comprehensive Gibco portfolio. Its range spans cell culture media, supplements, and reagents, which are used across routine research and bioprocessing workflows. In recent years, Thermo has also expanded its capacity to protect supply for biologics and vaccine manufacturing demand. For advanced therapies, the Gibco CTS portfolio supports cell and gene therapy programs with GMP-manufactured products and regulatory documentation. This mix of installed base, recurring consumables, and manufacturing scale keeps Thermo strongly positioned across North America’s research and bioproduction demand.

Danaher Corporation is a key player in the North America cell culture market, primarily through Cytiva and Pall Life Sciences, which are currently integrated under the Cytiva brand. On the production side, Cytiva supports mammalian cell culture scale-up with Xcellerex X-platform single-use bioreactors (10 L to 2000 L) and other upstream systems used in pilot to cGMP setups. This mix of recurring consumables and upstream platforms, along with bioprocess services, positions Danaher strategically with biopharma manufacturers across North America. Cytiva also manufactures cell culture media in the US, which helps with regional supply reliability.

Corning Incorporated is a key player in cell culture consumables in North America, with deep adoption across research and bioproduction labs. Through its Corning and Falcon brands, it supplies high-use items such as plastic vessels, specialty surfaces, and cell culture media/serum used in drug discovery, advanced cell culture, and bioproduction. Corning also plays a strong role in 3D biology through the Matrigel Matrix for organoids, supporting the consistent culture of organoids in translational research. This blend of everyday repeat-purchase plastics plus premium scale-up and 3D tools keeps Corning well-positioned in the North America cell culture market.

Market Ranking

The North America cell culture market is competitive, with global suppliers gaining share through broad consumables portfolios and reliable supply. Thermo Fisher Scientific is among the leaders, anchored by Gibco cell culture media, reagents, supplements, and sera, along with custom media and bioproduction support that fit both research and regulated workflows. Danaher (Cytiva) is also a key force through HyClone media and feeds, backed by defined/animal component-free options and a manufacturing presence that supports regional supply, alongside upstream platforms like single-use bioreactors for scale-up. Corning Incorporated leads strongly in cell culture vessels and advanced culture tools, including HYPERStack/HYPERFlask for high-yield adherent expansion and Matrigel solutions for organoid workflows. Across end users, buying decisions increasingly tilt toward consistency, documentation, ease of use, and scalable workflows, keeping consumables and platform-related repeat demand at the center of competition.

Related Reports:

North America Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com